CSPC Innovation Pharmaceutical Co., Ltd.

Shenzhen Stock Exchange 300765.SZ

CSPC Innovation Pharmaceutical Co., Ltd. Shareholders' Equity for the year ending December 31, 2023: USD 715.35 M

CSPC Innovation Pharmaceutical Co., Ltd. Shareholders' Equity is USD 715.35 M for the year ending December 31, 2023, a 25.43% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.

CSPC Innovation Pharmaceutical Co., Ltd. Shareholders' Equity for the year ending December 31, 2022 was USD 570.31 M, a 22.75% change year over year.
CSPC Innovation Pharmaceutical Co., Ltd. Shareholders' Equity for the year ending December 31, 2021 was USD 464.60 M, a 13.24% change year over year.
CSPC Innovation Pharmaceutical Co., Ltd. Shareholders' Equity for the year ending December 31, 2020 was USD 410.29 M, a 18.73% change year over year.
CSPC Innovation Pharmaceutical Co., Ltd. Shareholders' Equity for the year ending December 31, 2019 was USD 345.56 M, a 139.88% change year over year.

Key data

Date	Shareholders' Equity	Minority Interest	Total Equity	Total Stockholders Equity and Liabilities

Shenzhen Stock Exchange: 300765.SZ

CSPC Innovation Pharmaceutical Co., Ltd.

CEO	Mr. Feng Han
IPO Date	March 22, 2019
Location	China
Headquarters	No. 36, Fuqiang Western Road
Employees	1,887
Sector	Consumers Staples
Industries Non-Alcoholic Beverages Alcoholic Beverages Consumer Packaged Goods Drugstores & Retail Pharmacies Pharmaceuticals Soft Drinks & Sodas Tobacco

Description

CSPC Innovation Pharmaceutical Co., Ltd. manufactures and sells caffeine, and vitamin C health supplement and beverage products. The company is based in Shijiazhuang, China. CSPC Innovation Pharmaceutical Co., Ltd. is a subsidiary of CSPC Pharmaceutical Group Limited.

Key trends

Past 5 years